By Matt Grossman

 

Bristol Myers Squibb Co. on Wednesday narrowed the range of its full-year adjusted-earnings guidance.

The New York City-based pharmaceutical company said it now expects adjusted earnings of $7.40 a share to $7.55 a share. Previously, it forecasted adjusted earnings of $7.35 a share to $7.55 a share.

The guidance assumes world-wide revenue growth in the high single digits, Bristol said.

Marketing, selling and administrative expenses will be in line with 2020 levels, while research and development expenses is likely to increase by a low-single-digits percentage, the company estimated.

 

Write to Matt Grossman at matt.grossman@wsj.com

 

(END) Dow Jones Newswires

October 27, 2021 07:36 ET (11:36 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Nov 2021 to Dec 2021 Click Here for more Bristol Myers Squibb Charts.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Dec 2020 to Dec 2021 Click Here for more Bristol Myers Squibb Charts.